AzTrials
AzTrials

Colo-rectal CancerNCT03623152

Colorectal Neoplasia and Microbiota: Does Left Equal Right?

An observational study of Colo-rectal Cancer, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Many studies, including our own, have shown that colorectal cancer (CRC) is related to changes in the microbiome of the colon. However, there are limitations in most studies and questions remained unanswered. Some early data showing that the microbiome in the left vs right colon are different. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Colo-rectal Cancer
How many people
160 participants
Where
1 siteHong Kong
Study dates
7 Aug 2018to 6 Oct 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients have scheduled colonoscopy

Who may be able to join

  • >18 years of age, with the informed consent of the study-specific colonoscopy examination method and samples collection
  • have an indication for a scheduled colonoscopy, either as an investigation of colorectal symptom or as part of a CRC screening
  • for those who are known to have either adenoma or CRC, colonoscopy is arranged for endoscopic submucosal dissection (ESD) or endoscopic mucosectomy (EMR)

Who cannot join

  • known history of coagulopathy b. recently on antithrombotics or antiplatelets c. recently on antibiotics, prebiotics, probiotics and symbiotics d. anticipated prolonged standard colonoscopy procedure at endoscopist's discretion e. consent cannot be obtained
  • -

Trial locations and contacts

1 site in 1 country.

Yuet Ling Ching contact

35053524

jessicaching@cuhk.edu.hk

Ming Yeung Ho contact

26371398

andrewho@cuhk.edu.hk

Hong Kong1 site, 1 recruiting
  • Endoscopy Center, Prince of Wales Hospital

    Hong Kong

    Fanny Cheung', 35052231

    Recruiting

Other trials in Hong Kong

About this study

Many studies, including our own, have shown that colorectal cancer (CRC) is related to changes in the microbiome of the colon. However, there are limitations in most studies and questions remained unanswered. Some early data showing that the microbiome in the left vs right colon are different.

The aim of this study is to investigate the microbiome (including bacteriome, virome, and fungome) of adenoma/CRC comparing the left (distal to splenic flexure) vs right side (proximal to splenic flexure) of the colon.

Read the detailed description
  1. Many studies, including our own, have shown that colorectal cancer (CRC) is related to changes in the microbiome of the colon
  2. Certain bacterial phyla are more frequently presented in CRC
  3. Bacterial diversity is reduced in CRC
  4. Co-occurrence of bacterial phyla and exclusion are identified in CRC
  5. Besides bacteriome, viromes have been found associated with CRC
  6. These changes in the pattern may actually be used for diagnosis and prognosticate purposes.
  7. However, there are limitations in most studies and questions remained unanswered
  8. Most studies used stool sample and data of tissue (tumor and adjacent normal tissues) may not be available
  9. Most studies take adenoma and CRC as one condition, without differentiating the findings according to tumor location
  10. Most studies have separate bacteria, virus and fungi. There is a lack of data on their interaction
  11. Most studies have identified either microbiome without correlating them with the genomic of the host
  12. We know that not all CRC are the same. It has been known that rectal and colonic cancer are not the same. Furthermore, proximal (right) CRC and distal (left) CRC may not be the same.
  13. Studies have shown compare to L-CRC, patients with R-CRC are older, more female (Iaocopetta B et al. Int J Cancer 2002)
  14. Studies have also shown that the genomic make up of L-CRC and R-CRC are different. R-CRC are more likely to have family cancer syndrome (HNPCC), mostly diploid, less frequent to have loss heterozygosity, less TP53 mutations and more MSI and CIMP, and the gene expression are different (Glebov et al. Cancer Epi, Biomarker and Prevention 2003)
  15. The response to therapy might also be different in the L-CRC compare to R-CRC
  16. Recent studies show that the clinico-pathological and molecular features of early-onset (<50 years) CRC varies according to tumor location. (Peres J et al. Am J Cancer Res 2015). In the R-CRC in this group, germline mutation is more common (MLH1, MSH2, MSH6, PMS2 and EPCAM). Adenomas tend to be larger, flatter and more likely to have high-grade dysplasia and villous histology
  17. Recent studies have also shown that the clinic-pathological and molecular feature of in the late-onset CRC (70-80 years) varies with tumor location (Brandariz et al. Oncotarget 2018). There are more sporadic MSI, more BRAF mutation and the adenoma/CRC are likely to be mucinous.
  18. Studies comparing the microbiome of L-CRC vs R-CRC has not been many. There is some early data showing that the microbiome in the left vs right colon are different.

The aim of this study is to investigate the microbiome (including bacteriome, virome, and fungome) of adenoma/CRC comparing the left (distal to splenic flexure) vs right side (proximal to splenic flexure) of the colon.

Medical subject headings
Colonic Neoplasms

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Descriptive statistics will be used for demographics data

    Since the sample size is small, non-parametric chi-square test or Mann-Whitney tests will be used for the comparison of the clinical data between the cases with adenoma or CRC on the right and left side colon.

    Measured: All biological samples will be stored for a maximum of 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2018
  2. Study start7 Aug 2018
  3. Primary completion6 Sep 2019 (estimated)
  4. Study completion6 Oct 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03623152
Sponsor's protocol ID
CRC MIC L&R
Status last verified
Jul 2019
First submitted
7 Aug 2018
Last updated
24 Jul 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Colo-rectal Cancer, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yuet Ling Ching (35053524, jessicaching@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Descriptive statistics will be used for demographics data (time frame: All biological samples will be stored for a maximum of 10 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in